XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 16, 2025
Jun. 05, 2025
Mar. 20, 2025
Feb. 14, 2025
Feb. 06, 2024
Feb. 05, 2024
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Mar. 31, 2024
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Cash issuance costs                     $ 72,805    
Shares held in abeyance 1,138,055     1,138,055       1,138,055   1,201,580 1,138,055 1,201,580   1,351,580
Weighted average grant date fair value of stock options granted               $ 1.37     $ 1.87 $ 1.11    
Issuance and sale of common stock, net of issuance costs               $ 888,138 [1] $ 901,610 [2]          
Net proceeds from shares sold                     $ 2,011,250    
Deferred offering costs reclassified to additional paid-in capital                     148,697      
Repurchase of common stock $ 0                          
Gross proceeds from exercise of options                     $ 42,411    
Share-Based Payment Arrangement, Option [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Options granted                     2,177,908      
Exercise price of options granted                     $ 2.45      
Shares issued upon exercise of options                     29,249      
Exercise price of options exercised                     $ 1.45      
Gross proceeds from exercise of options                     $ 42,411      
Share-Based Payment Arrangement, Option [Member] | Share-Based Payment Arrangement, Employee [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Options granted     25,000   2,152,908                  
Exercise price of options granted     $ 1.78   $ 2.46                  
Grant date fair value of options granted     $ 34,250   $ 4,044,250                  
Vesting of options description     vests as follows: to the extent of 50% immediately with the remainder vesting quarterly over two years commencing one year from the date of grant   vest as follows: (i) options to purchase an aggregate 323,459 shares of common stock vest monthly over one year, and (ii) options to purchase an aggregate of 1,829,449 shares of common stock vest to the extent of 50% immediately with the remainder vesting quarterly over two years commencing one year from the date of grant                  
Board Of Director [Member] | Minimum [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Repurchase of common stock   $ 2,000,000                        
Common Stock [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Warrants exercisable           3,351,580                
Exercise price           $ 2.33                
Proceeds from exercise of warrants           $ 8,100,000                
Cash issuance costs           $ 595,364                
Number of shares sold               473,337 [1] 492,087 [2]          
Shares issued                     2,213,525      
Issuance and sale of common stock, net of issuance costs               $ 47 [1] $ 49 [2]          
Abeyance shares issued                 63,525 150,000        
Shares issued upon exercise of options                 29,249          
Common Stock [Member] | Roth Capital Partners LLC [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Cash fee for services             $ 528,000              
Common Stock [Member] | Private Placement [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Warrants exercisable           2,513,686                
Exercise price           $ 2.43                
Warrants for cash and the payment           $ 0.125                
Common Stock [Member] | 2024 ATM Program [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Number of shares sold                     965,424      
Issuance and sale of common stock, net of issuance costs                     $ 2,011,250      
Commissions, legal and accounting fees                     72,805      
Net proceeds from shares sold                     $ 1,938,445      
Common Stock [Member] | Auctus Fund, LLC [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Shares held in abeyance                         1,201,580  
Number of shares sold       63,525                    
Abeyance shares issued                     63,525      
Warrant [Member] | Roth Capital Partners LLC [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Issuance costs                       $ 595,364    
[1] Represents the gross proceeds of $927,335, less issuance costs of $39,197, resulting in net proceeds of $888,138. See Note 4 - Stockholders’ Equity - ATM Sales for additional details.
[2] Represents the gross proceeds of $1,083,915, less issuance costs of $182,305, resulting in net proceeds of $901,610. See Note 4 - Stockholders’ Equity - ATM Sales for additional details.